Farmacología y fisiopatología vascular
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (6)
2024
-
Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes
Nature Cardiovascular Research, Vol. 3, Núm. 2, pp. 203-220
2023
-
Oxidized soluble guanylyl cyclase causes erectile dysfunction in alcoholic mice
British Journal of Pharmacology, Vol. 180, Núm. 18, pp. 2361-2376
-
Sigma-1 receptor modulation fine-tunes KV1.5 channels and impacts pulmonary vascular function
Pharmacological Research, Vol. 189
2020
-
Gut DYSBIOSIS and altered barrier function precedes the appearance of metabolic syndrome in a rat model of nutrient-induced catch-up growth
Journal of Nutritional Biochemistry, Vol. 81
2019
-
Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension
Journal of Physiology, Vol. 597, Núm. 4, pp. 1087-1101
-
Exploring clinical, echocardiographic and molecular biomarkers to predict bronchopulmonary dysplasia
PLoS ONE, Vol. 14, Núm. 3